Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro
Authors
Keywords
Colorectal cancer, Fluorouracil, Oxaliplatin, Drug combination, Chou-Talalay
Journal
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
Volume 53, Issue 5, Pages 435-447
Publisher
Springer Nature
Online
2017-01-25
DOI
10.1007/s11626-016-0126-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells
- (2016) Cynthia Morata-Tarifa et al. Scientific Reports
- Radioactive 125I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway
- (2015) Yunhong Tian et al. BMC CANCER
- Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
- (2015) A. Goodspeed et al. MOLECULAR CANCER RESEARCH
- Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.
- (2015) María José Escamez et al. Oncotarget
- Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
- (2014) Rasheena Edmondson et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Circulating tumor cells
- (2014) Cristina Raimondi et al. CANCER BIOLOGY & THERAPY
- The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer
- (2014) Terence W. Friedlander et al. JOURNAL OF CLINICAL ONCOLOGY
- Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells
- (2014) Rebecca A. Rowehl et al. PLoS One
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Cancer heterogeneity: implications for targeted therapeutics
- (2013) R Fisher et al. BRITISH JOURNAL OF CANCER
- Culture of low passage colorectal cancer cells and demonstration of variation in selected tumour marker expression
- (2013) Melanie Arul et al. CYTOTECHNOLOGY
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation
- (2013) M. Christmann et al. NUCLEIC ACIDS RESEARCH
- Down-Regulation of BAX Gene During Carcinogenesis and Acquisition of Resistance to 5-FU in Colorectal Cancer
- (2013) Mehdi Manoochehri et al. PATHOLOGY & ONCOLOGY RESEARCH
- Technologies for deriving primary tumor cells for use in personalized cancer therapy
- (2013) Abhisek Mitra et al. TRENDS IN BIOTECHNOLOGY
- Epigenetic and genetic features of 24 colon cancer cell lines
- (2013) D Ahmed et al. Oncogenesis
- Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line
- (2012) Shatha AbuHammad et al. GENOMICS
- Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
- (2012) Kaori Kadoyama et al. International Journal of Medical Sciences
- Tumor suppressor gene p16/INK4A/CDKN2A-dependent regulation into and out of the cell cycle in a spontaneous canine model of breast cancer
- (2012) Payal Agarwal et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The complexity of prostate cancer: genomic alterations and heterogeneity
- (2012) Lara K. Boyd et al. Nature Reviews Urology
- Establishment of Human Ultra-Low Passage Colorectal Cancer Cell Lines Using Spheroids from Fresh Surgical Specimens Suitable for In Vitro and In Vivo Studies
- (2012) Satyajit Ray et al. Journal of Cancer
- STATing the importance of immune modulation by platinum chemotherapeutics
- (2012) Stanleyson V. Hato et al. OncoImmunology
- Circulating Tumor Cells: The Substrate of Personalized Medicine?
- (2012) Bryan T. Greene et al. Frontiers in Oncology
- A Rapid and Simple Procedure for the Establishment of Human Normal and Cancer Renal Primary Cell Cultures from Surgical Specimens
- (2011) Maria João Valente et al. PLoS One
- Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
- (2010) Elsa Quintana et al. CANCER CELL
- Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers
- (2010) Ja-Lok Ku et al. CARCINOGENESIS
- Cellular Heterogeneity: Do Differences Make a Difference?
- (2010) Steven J. Altschuler et al. CELL
- Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines
- (2009) Sara Nannizzi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
- (2009) Felipe C Geyer et al. JOURNAL OF PATHOLOGY
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
- (2008) Scott J. Dylla et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started